-+ 0.00%
-+ 0.00%
-+ 0.00%

ADDEX SPIN-OUT NEUROSTERIX HAS STARTED A PHASE 1 CLINICAL STUDY WITH M4 PAM - NTX-253 FOR SCHIZOPHRENIA

Reuters·01/07/2026 06:00:41

Please log in to view news